Dr. Vijay Palwe

Consultant - Radiation Oncology

Home / Our Doctors / Dr. Vijay Palwe

Dr. Vijay Palwe

Consultant - Radiation Oncology

  Qualification

MBBS, MD (Radiation Oncology)16 years’ experience, PDCR (Radiation Oncology)

  Experience

16 Years

  Specialities

Radiation Oncology

  Email

info@manavatacancercentre.com

  Check Availability

Book an Appointment

with Dr. Vijay Palwe

Introduction
Expertise
  • Dr. Vijay’s expertise lies in the management of all types of malignant and benign tumours and oncological emergencies.
  • He is well trained in conventional, 3DCRT, IMRT and IGRT based treatments, with a special interest in head and neck cancers, breast cancers and gynaecological cancers, brachytherapy (head & neck, breast, soft tissue sarcoma, cervix, vault) SRS, SAT, SRT,SBRT, DIBH.
  • He has handled more than 16,000 cases so far.
Training and Certifications
  • Underwent training for Tomotherapy at Clinica Luganese, Lugano, Switzerland in June 2017
Recognition
  • JRD Tata Scholarship 2001 (MBBS)
  • MASCC/ISOO Travel scholarship for annual meeting2010 at Vancouver, Canada (June 2010)
  • MASCC/ISOO Membership scholarship 2010 &2011
  • Certificate of Merit from MUHS (2010-2011) for success in M.D. (Radiation Oncology) Exams held in 2009.
Publications
  • Objective assessment of swallowing function after definitive concurrent (chemo) radiotherapy in patients with head and neck cancer (2011). Dysphagia, 26(4), 399-406.
  • Prospective subjective evaluation of swallowing function and dietary pattern in head and neck cancers treated with concomitant chemo-radiation (2010) Journal of cancer research and therapeutics, 6(1), 15.
  • Prevalence of molecular subtypes of breast cancer: a single institutional experience of 2062 patients (2020). European journal of breast health, 16(1), 39.
  • Encyclopedic tumor analysis for guiding treatment of advanced, broadly refractory cancers: results from the RESILIENT trial (2019). Oncotarget, 10(54), 5605.
  • The predictive role of neutrophil-to-lymphocyte ratio in the outcomes of patients with sarcomatoid carcinoma of oral cavity (2021). European Archives of Oto-Rhino-Laryngology, 1-9.
  • Factors influencing non-adherence to radiotherapy: a retrospective audit of 1,548 patients from a tertiary cancer centre (2020). Journal of Radiotherapy in Practice, 19(4), 359-364.
  • Evaluation of Prognostic Factors that Affect Survival Outcomes of Breast Cancer Patients with Brain Metastases: A Single Institutional Experience (2021). European Journal of Breast Health, 17(1), 62.

Availability at Hospital

Sl.No Day Timing Evening Round
1 Monday 10AM-7PM 7PM-8PM
2 Tuesday 10AM-7PM 7PM-8PM
3 Wednesday 10AM-7PM 7PM-8PM
4 Thursday 10AM-7PM 7PM-8PM
5 Friday 10AM-7PM 7PM-8PM
6 Saturday 10AM-7PM 7PM-8PM

Other Doctors

Book An Appointment